The DCRI welcomes new faculty members

July 10, 2018 – The seven new faculty members come from the departments of Pediatrics, Cardiology, Neurology, and others.

Stephen J. Balevic, MD, MHS

Stephen J. Balevic, MD, MHS, joined the DCRI on July 1 as an assistant professor in the departments of Pediatrics and Internal Medicine at Duke University Medical Center. He was most recently an adult and pediatric rheumatology fellow at Duke University, and a pediatric clinical research fellow at the DCRI.

Balevic completed medical school at the Marshall University School of Medicine in his home state of West Virginia, and a combined internal medicine and pediatric residency at the Medical University of South Carolina. He obtained his MHS degree with a concentration in clinical pharmacology through the Clinical Research Training Program at Duke University/UNC School of Pharmacy, and his bachelor’s degree from UNC-Chapel Hill.

Balevic’s research interests are in clinical pharmacology, precision medicine, and clinical trials.

Satasuk Joy Bhosai, MD, MPH

Satasuk Joy Bhosai Satasuk Joy Bhosai, MD, MPH, joined the DCRI on July 1 as a Hospitalist Physician with Duke Health and a member of the executive leadership team for the DCRI Innovations group. Most recently she completed her residency at Duke, during which time she completed the Duke Management and Leadership Program. In that program, Bhosai designed multiple health systems leadership initiatives focused on patient safety, quality improvement, and digital innovations.

She earned her medical degree from the University of California, San Francisco, completing the global health pathways program. She holds an MPH degree with a focus in health management from Yale University, School of Public Health and Yale School of Management, as well as bachelor’s degrees in anthropology and neuroscience from Pomona College. She was a Fulbright scholar at the National Cancer Institute/Prince Mahavahiralongkorn Cancer Center in Thailand.

Bhosai’s work addresses gaps in access to high-quality care. Through previous public health work in Africa and Asia, she developed innovations dedicated to improving access to health services. She is the co-founder of ChatrHealth, a software group that specializes in creating patient safety applications for hospitals and providers, which has been supported by large academic centers and the World Bank. Bhosai has worked with Health 2.0, directing the Matchpoint program, which pairs industry leaders with health tech startups.

Michael L. James, MD, FAHA, FNCS

Luke JamesMichael L. (Luke) James, MD, FAHA, FNCS, joined the DCRI as an associate professor of anesthesiology and neurology on April 1. He is also associate director of Duke Clinical Anesthesiology Research Endeavors (CARE), a departmental initiative to further organize clinical research efforts in all areas of anesthesia and perioperative research at Duke University, and associate director of the Duke Brain Injury Translational Research Center.

James joined the Duke faculty in 2006 and has been the Duke principal investigator for multiple large, multi-center intracerebral hemorrhage and brain trauma trials. He has served in the clinical research unit for anesthesiology, as part of the neurocognitive core for the Cardiothoracic Surgical Trials Network, on the Duke IRB, and at Duke’s sister medical school in Singapore.

In addition to maintaining an active clinical practice, in recent years James’s focus has shifted towards clinical research. He and his research collaborators continue to advance translatable therapeutic opportunities into human investigation for acute intracerebral hemorrhage and brain trauma. Their current research focuses on noninvasive measurement of brain temperature and metabolism, systemic effects of acute neurological injury, gonadal hormone modulation of neuroinflammation, and the therapeutic potential of apoE-mimetic peptides.

James has worked to foster long-term multidisciplinary collaboration in all subspecialties that practice neurocritical care. He has served on the Board of Directors of the Society for Neuroscience in Anesthesiology and Critical Care, represent the Neurocritical Care subspecialty at the United Council of Neurological Subspecialties, and played central roles in the Neurocritical Care Society and Society of Critical Care Medicine.

James received his MD degree from Louisiana State University and his bachelor’s degree from Vanderbilt University. He completed residencies in neurology and anesthesiology with fellowships in neurocritical care, neuroanesthesia, and vascular neurology.

Amber J. Oberle, MD

Amber OberleAmber J. Oberle, MD, joined the DCRI as a medical instructor in the Department of Medicine’s Pulmonary, Allergy, and Critical Care division on July 1.

She earned her medical degree from Creighton University School of Medicine in Omaha, NE and completed a residency in internal medicine and a fellowship in pulmonary and critical care medicine at Indiana University. She holds a BS degree in chemistry from Creighton University.

Oberle’s research focuses on asthma and other pulmonary diseases. While at Indiana University, she founded the Adult Asthma Center, dedicated to managing severe asthma and complex airway diseases. Oberle is a member of the American Thoracic Society and the American College of Chest Physicians.


Kishan S. Parikh, MD

Kishan ParikhKishan S. Parikh, MD, joined the DCRI as an assistant professor in the Department of Medicine’s Cardiology division on July 1. He most recently completed a fellowship in Advanced Heart Failure, Mechanical Circulatory Support, and Transplant at Duke University. Prior to that, he was a cardiology fellow at Duke, where he was chief cardiovascular fellow, and a clinical research fellow at the DCRI under the mentorship of Adrian Hernandez and G. Michael Felker. He also pursed additional coursework in clinical pharmacology training at the UNC Eshelman School of Pharmacy during his DCRI fellowship.

He earned his medical degree from Feinberg School of Medicine, Northwestern University and completed his residency in the Department of Medicine, University of Chicago, where he served as chief resident. He holds a bachelor’s degree in biology from Northwestern.

Parikh’s research interests are focused on improving care for pulmonary hypertension and heart failure, and bringing the fields closer to the concept of targeted therapy. More specifically, he aims to integrate the clinical approach to pulmonary hypertension and heart failure with prediction of therapeutic response. He currently serves as co-principal investigator and principal investigator for several Phase I and II trials of investigational agents and mobile health monitoring in pulmonary hypertension, and he led a first-in-man study of invasive hemodynamic monitoring in pulmonary arterial hypertension. He also has studied use of pharmacogenetics in heart failure.

He served on the Medicare Evidence Development and Coverage Advisory Committee (MEDCAC) for Peripheral Venous Disease and continues to serve as a Duke Margolis Center for Policy fellow focused on the use of real-world evidence in regulatory decision making. He helped plan and synthesize a report for a recent DCRI Think Tank on heart failure with preserved ejection fraction.

 Kathleen Welsh-Bohmer, PhD

Kathleen Welsh-BohmerKathleen (Kathie) Welsh-Bohmer, PhD, joined the DCRI on May 1 to lead Alzheimer’s disease trials. She is a professor of psychiatry and neurology at Duke University as well as the chief of the Medical Psychology Clinical Professional Unit, the professional home for the more than 200 academic psychologists within the Duke Health system.

Clinically trained as a neuropsychologist, Welsh-Bohmer’s research activities have been focused on developing effective prevention and treatment strategies to delay the onset of cognitive disorders occurring in later life. She was the principal investigator of the Cache County Memory Study, an epidemiological study of an exceptionally long-lived population that established key environmental modifiers affecting Alzheimer’s disease onset and progression.

Since 2006 Welsh-Bohmer has directed the Joseph and Kathleen Bryan Alzheimer’s Center in the Duke Department of Neurology, where she leads a large multidisciplinary team focused on discovering the biological basis of Alzheimer’s disease and developing methods to enhance early diagnosis and speed drug discovery. Since 2011, she has led the neuropsychology scientific operations of a Phase III global clinical trial to delay the onset of Alzheimer’s disease entitled the “TOMMORROW” study.

Welsh-Bohmer joined the Duke University faculty in 1987. She received her PhD and master’s degree from the University of Virginia, postdoctoral specialization in neuropsychology from the University of Iowa, and her bachelor’s degree from Duke. She is board certified by the American Psychological Association in the practice of neuropsychology.

Christina M. Wyatt, MD

Christina M. Wyatt, MD, joined the DCRI as an associate professor in the Department of Medicine’s Nephrology division and an associate director for the DCRI fellowship program on July 1. Prior to joining the DCRI, she was an associate professor in the Department of Medicine, Division of Nephrology, Icahn School of Medicine at Mount Sinai in New York. Since 2017, she served as Associate Chair for Clinical and Translational Research in the Mount Sinai Department of Medicine.

Wyatt earned her medical degree from Duke University School of Medicine. She completed her residency and was chief resident in the Department of Medicine and completed a fellowship in the Division of Nephrology at the Mount Sinai School of Medicine. She also holds an MS degree in biostatistics with a focus on clinical research methods from Columbia University’s Mailman School of Public Health. She received her bachelor’s degree in history from Duke.

Wyatt’s research focuses on nephrology and kidney disease, particularly kidney disease and medication toxicity in patients with or at risk for HIV infection. She has published extensively on these topics and currently serves on the editorial boards of Kidney International and JAIDS. She is a member of numerous scientific working groups and is on the Executive Committee for Kidney Disease: Improving Global Outcomes (KDIGO), an international guidelines organization.​